Perifosine as potential anti-cancer agent inhibits proliferation, migration, and tube formation of human umbilical vein endothelial cells

被引:1
作者
Feng Ze Wang
Hong Rong Fei
Xiao Qian Li
Renjiu Shi
De Cai Wang
机构
[1] Taishan Medical University,School of Biological Science
[2] Taishan Medical University,Institute of Medicinal Biotechnology
[3] Taishan Medical University,School of Pharmacy
来源
Molecular and Cellular Biochemistry | 2012年 / 368卷
关键词
HUVEC; Perifosine; PI3K/Akt; Angiogenesis;
D O I
暂无
中图分类号
学科分类号
摘要
Targeting angiogenesis is considered an effective strategy for treating the expansion and metastasis of tumors. The aim of this study is to assess the effects of perifosine, an inhibitor of Akt, on cell proliferation, apoptosis, angiogenesis, and VEGF-induced cell migration in cultured human umbilical vein endothelial cells (HUVECs) in vitro. MTT and cell cycle analysis results indicated that perifosine inhibited the growth of HUVECs in a dose-dependent manner, arrested cell cycle progression at the G2 phase with regulation the expression of p21 and cyclinB1. Apoptosis induced by the higher concentrations of perifosine in HUVECs was also observed. In addition, tube formation of HUVECs and VEGF-induced cell migration were markedly inhibited by perifosine. Western blotting analysis of cell signaling molecules indicated that perifosine inhibited ERK and p38 phosphorylation in HUVECs. These results suggest that perifosine exerts anti-angiogenic activity in HUVECs and is a promising agent for treatment of angiogenesis related-diseases.
引用
收藏
页码:1 / 8
页数:7
相关论文
共 126 条
[1]  
Folkman J(2006)Angiogenesis Annu Rev Med 57 1-18
[2]  
Libert N(2010)Inhibitors of angiogenesis: new hopes for oncologists new challenges for anesthesiologists Anesthesiology 113 704-712
[3]  
Tourtier JP(2010)Angiogenesis inhibitors: current strategies and future prospects CA Cancer J Clin 60 222-243
[4]  
Védrine L(2010)Angiogenesis as a therapeutic target in urothelial carcinoma Anticancer Drugs 21 890-896
[5]  
Chargari C(2011)Hispidulin, a small flavonoid molecule, suppresses the angiogenesis and growth of human pancreatic cancer by targeting vascular endothelial growth factor receptor 2-mediated PI3K/Akt/mTOR signaling pathway Cancer Sci 102 219-225
[6]  
Cook KM(2010)MMP-2 alters VEGF expression via alphaVbeta3 integrin-mediated PI3K/AKT signaling in A549 lung cancer cells Int J Cancer 127 1081-1095
[7]  
Figg WD(2011)Sox9 sustains chondrocyte survival and hypertrophy in part through Pik3ca–Akt pathways Development 138 1507-1519
[8]  
Pinto A(2011)ATM-dependent ERK signaling via AKT in response to DNA double-strand breaks Cell Cycle 10 481-491
[9]  
Redondo A(2011)Critical role of PI3K signaling for NF-kappaB-dependent survival in a subset of activated B-cell-like diffuse large B-cell lymphoma cells Proc Natl Acad Sci USA 108 272-277
[10]  
Zamora P(2009)PI3K/PTEN signaling in angiogenesis and tumorigenesis Adv Cancer Res 102 19-65